» Articles » PMID: 11412571

[Can or Should Blood Pressure Be Measured at Pharmacy Offices?]

Overview
Journal Aten Primaria
Specialty Public Health
Date 2001 Jun 20
PMID 11412571
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate concordance between blood-pressure (BP) measurements at the pharmacy office (PhO) and the nurse office (NO) in the health care centre (HCC).

Design: Descriptive study.

Setting: Community.

Methods: 36 PhO have voluntarily participated in the province of Albacete, where they have done 3 BP measures, without previous instructions and with their usual measurements devices, for 3-5 subjects, who were referred to their HCC so that they were taken another 3 BP measures in the NO with their Hg sphymomanometer and in their usual measure conditions (blind measures in relation to those taken at the PhO). These subjects were given a stamped envelope to send the BP measurements (taken at the NO), to the Official Pharmacy College.

Results: The 6 BP measurements have been completed to 96 subjects with an average of 57.3 years old (women 63%). The differences between PhO and NO were > 5 mmHg in 58 subjects (60.4%) in the case of SBP and in 45 subjects (46.9%) in the case of DBP, and it was more than 15 mmHg in the 17 subjects (17.7%) with SBP and in 9 subjects (9.4%) with DBP. The difference average was 9.5 mmHg (SD, 8.4 mmHg) and 6.4 mmHg (SD, 5.3 mmHg) respectively. The use rate of digit 0 was 22% at the PhO and 46.5% at the NO. In most of PhO, measurement electronic devices have been used for the BP, but not validated for clinical use.

Conclusions: The PhO can be a good place for the hypertension screening, but the chemist must be trained in the BP correct measurement and use validated electronic devices. Standardization measurement conditions and the use of validated electronic devices must be extended to the NO.

Citing Articles

A comparison of blood pressure in community pharmacies with ambulatory, home and general practitioner office readings: systematic review and meta-analysis.

Albasri A, OSullivan J, Roberts N, Prinjha S, McManus R, Sheppard J J Hypertens. 2017; 35(10):1919-1928.

PMID: 28594707 PMC: 5585128. DOI: 10.1097/HJH.0000000000001443.


Clinical value of blood pressure measurement in the community pharmacy.

Sabater-Hernandez D, Azpilicueta I, Sanchez-Villegas P, Amariles P, Baena M, Faus M Pharm World Sci. 2010; 32(5):552-8.

PMID: 20652831 DOI: 10.1007/s11096-010-9419-4.


[Measurement of blood pressure in the pharmacy].

Martin Rioboo E, Fonseca Del Pozo F, Ripolles Orti M, Diaz Moreno A Aten Primaria. 2001; 28(7):511-3.

PMID: 11718653 PMC: 7676015. DOI: 10.1016/s0212-6567(01)70435-0.

References
1.
Llanes de Torres R, Aragon Pena A, Sillero Quintana M, Martin Rios M . [Go to the health center or go to the drug store? Pharmacy offices as a primary care resource]. Aten Primaria. 2000; 26(1):11-5. PMC: 7681453. DOI: 10.1016/s0212-6567(00)78598-2. View

2.
Prieto L, Lamarca R, Casado A . [Assessment of the reliability of clinical findings: the intraclass correlation coefficient]. Med Clin (Barc). 1998; 110(4):142-5. View

3.
Puras A, Sanchis C, Artigao L, Divison J . Prevalence, awareness, treatment, and control of hypertension in a Spanish population. Eur J Epidemiol. 1998; 14(1):31-6. DOI: 10.1023/a:1007483916158. View

4.
Bland J, Altman D . Comparing two methods of clinical measurement: a personal history. Int J Epidemiol. 1995; 24 Suppl 1:S7-14. DOI: 10.1093/ije/24.supplement_1.s7. View

5.
Villar Alvarez F, Banegas Banegas J, Rodriguez Artalejo F, DEL REY CALERO J . [Cardiovascular mortality in Spain and its autonomous communities (1975-1992)]. Med Clin (Barc). 1998; 110(9):321-7. View